Synthesis and anti-Helicobacter pylori activity of 4-(coumarin-3-yl) thiazol-2-ylhydrazone derivatives

Journal of Heterocyclic Chemistry

Volumn 47, Issue 6, 2010, Pages 1269-1274

  Chimenti, Franco ^a   Bizzarri, Bruna ^a   Bolasco, Adriana ^a   Secci, Daniela ^a   Chimenti, Paola ^a   Granese, Arianna ^a   Carradori, Simone ^a   D'Ascenzio, Melissa ^a   Scaltrito, M Maddalena ^b   Sisto, Francesca ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 [1 (NAPHTHALEN 1 YL)METHYLEN]HYDRAZINYL]THIAZOL 4 YL] 2H CHROMEN 2 ONE; 3 [2 [2 [1 (PYRIDIN 3 YL)ETHYLIDEN]HYDRAZINYL]THIAZOL 4 YL] 2H CHROMEN 2 ONE; 4 (COUMARIN 3 YL)THIAZOL 2 YLHYDRAZONE DERIVATIVE; ACETIC ACID DERIVATIVE; BROMINE DERIVATIVE; COUMARIN DERIVATIVE; HYDRAZONE DERIVATIVE; METRONIDAZOLE; THIAZOLE DERIVATIVE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; HELICOBACTER PYLORI; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 78649674111     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.464     Document Type: Article

References (19)

1. Hunt, R. H., Scand J Gastroenterol 1996, 220, 3.
2. Bardhan, P. K., Clin Infect Dis 1997, 25, 973.
3. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 61; IARC: Lyon, 1994; pp 177-240.
4. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Carradori, S.; Granese, A.; Rivanera, D.; Lilli, D.; Scaltrito, M. M.; Brenciaglia, M. I., Eur J Med Chem 2006, 41, 208.
5. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Carradori, S.; Granese, A.; Rivanera, D.; Lilli, D.; Zicari, A.; Scaltrito, M. M.; Sisto, F., Bioorg Med Chem Lett 2007, 17, 3065.
6. Kawase, M.; Motohashi, N., Curr Med Chem Anti-Infect Agents 2004, 3, 89.
7. Chimenti, F.; Carradori, S.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Bizzarri, B., J Heterocycl Chem 2009, 46, 575.
8. Raghu, M.; Nagaraj, A.; Reddy, Ch. S., J Heterocycl Chem 2009, 46, 261.
9. Rao, V. R.; Reddy, M. M. M., Indian J Heterocycl Chem 2003, 13, 69.
10. Kalluraya, B.; Isloor, A. M.; Shenoy, S., Indian J Heterocycl Chem 2001, 11, 159.
11. Kalluraya, B.; Vishwanatha, P.; Isloor, A. M.; Rai, G.; Kotian, M., Bollettino Chimico Farmaceutico 2000, 139, 263.
12. Rao, V. R.; Kumar, V. R.; Vardhan, V. A., Phosphorus Sulfur 1999, 152, 257.
13. Srimanth, K.; Rao, V. R., Indian J Chem B 1999, 38B, 473.
14. Gursoy, A., J Fac Pharm Istanbul U 1974, 10, 57.
15. Gursoy, A.; Eczacilik F., J Fac Pharm Istanbul U 1973, 9, 51.
16. Rao, V. R.; Srimanth, K., J Chem Res S 2002, 9, 420.
17. Benassi, R.; Benedetti, A.; Taddei, F.; Cappelletti, R.; Nardi, D.; Tajana, A., Org Magn Reson 1982, 20, 26.
18. Cirilli, R.; Ferretti, R.; La Torre, F.; Secci, D.; Bolasco, A.; Carradori, S.; Pierini, M., J Chromatogr A 2007, 1172, 160.
19. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic bacteria. Approved standard M11-A6, 6th ed.; National Committee for Clinical Laboratory Standards: Villanova, PA, 2004.